ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$11.64
Tradestie Score
46
Market Cap
$226.82M
Revenue Growth
-0.2%
Analyst Upside
+87.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.30
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.16
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.37
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$38.73
|
$353.70M | 394.2 | 48 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.41
|
$350.98M | - | 68 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.75
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.46
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$6.87
|
$307.12M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.03
|
$304.12M | - | 56 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.59
|
$297.23M | - | 45 | Compare |
More ENTA Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry